Scholar Rock Holding Corp - Common Stock, par value $0.001 per share (SRRK)

CUSIP: 80706P103

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
+649,132
Put/Call ratio
27%
SEC-reported price per share
$8.33
Number of holders
162
Value change
-$4,950,113
Number of buys
98
Open additional details 1 more signal available
Number of sells
71
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
119,752,556

Security key

80706P103

Report period

Q2 2024

Institutions

162

Top holders

10

Ownership snapshot

Top reported holders of SRRK - Scholar Rock Holding Corp - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Samsara BioCapital GP, LLC
Disclosed value leader
Artal Group S.A.
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5 13F Highest disclosed value: $199,967,619 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Artal Group S.A. has the largest disclosed position value at $199.97M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Artal Group S.A.'s linked filing trail.
Disclosed position value Top 5
Samsara BioCapital GP, LLC $108.13M
Artal Group S.A. $199.97M
FMR LLC $188.3M
PRICE T ROWE ASSOCIATES INC /MD/ $145.78M
Samsara BioCapital, LLC $120.57M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Samsara BioCapital GP, LLC
3/4/5
10%+ Owner
—
denominator unverified
$108,133,716
6,788,609 shares
— 16 Oct 2023
Artal Group S.A.
13F
Company
13F
—
denominator unverified
$199,967,619
11,259,438 shares
— 31 Mar 2024
FMR LLC
13F
Company
13F
—
denominator unverified
$188,298,216
10,602,377 shares
— 31 Mar 2024
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$145,777,000
8,208,113 shares
— 31 Mar 2024
Samsara BioCapital, LLC
13F
Company
13F
—
denominator unverified
$120,565,696
6,788,609 shares
— 31 Mar 2024
Redmile Group, LLC
13F
Company
13F
—
denominator unverified
$114,012,274
6,419,610 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
162
Shares
85,434,499
Rows available
162
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
157
Q2 2024 holders
162
Holder diff
5
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .